About
Treatment for Cardiovascular and Neurodegenerative Disorders
Cognyxx Pharmaceuticals is developing a solution to empower the immune system in treatments for cardiovascular and neurodegenerative disorders.
Identity
| Name | Cognyxx Pharmaceuticals |
|---|---|
| Slug | cognyxx-pharmaceuticals |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMWAnoMLDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | - |
| HQ address | Derech Menachem Begin 132, Tel Aviv-Yafo, Israel |
Web & social
| Website | https://www.cognyxx.com |
|---|
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
degenerative-diseasesneurosciencecardiology
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}